Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions
Crispin, M., Bowden, T.A., Coles, C.H., Harlos, K., Aricescu, A.R., Harvey, D.J., Stuart, D.I., Jones, E.Y.(2009) J Mol Biol 387: 1061
- PubMed: 19236877
- DOI: https://doi.org/10.1016/j.jmb.2009.02.033
- Primary Citation of Related Structures:
2WAH - PubMed Abstract:
Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellular cytotoxicity, demonstrates that glycan engineering can bias the Fc to an open conformation primed for receptor binding.
Organizational Affiliation:
Division of Structural Biology, Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Headington, Oxford OX3 7BN, UK.